BIOMAT Database Logo BIOMAT Database Logo

Increased bioavailability of cimetidine with age? 1979

A Somogyi, and R Gugler

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

A Somogyi, and R Gugler
Doxepin-cimetidine interaction: increased doxepin bioavailability during cimetidine treatment.
February 1986, Journal of clinical psychopharmacology,
A Somogyi, and R Gugler
Bioavailability of coated cimetidine.
April 1985, Lancet (London, England),
A Somogyi, and R Gugler
Bioavailability of cimetidine in man.
February 1978, Gastroenterology,
A Somogyi, and R Gugler
Bioavailability and pharmacokinetics of cimetidine.
November 1979, European journal of clinical pharmacology,
A Somogyi, and R Gugler
Cimetidine and bioavailability of propranolol.
January 1981, Lancet (London, England),
A Somogyi, and R Gugler
Cimetidine and bioavailability of labetalol.
March 1981, Lancet (London, England),
A Somogyi, and R Gugler
Effect of cimetidine on quinidine bioavailability.
January 1989, Biopharmaceutics & drug disposition,
A Somogyi, and R Gugler
Cisapride-cimetidine interaction: enhanced cisapride bioavailability and accelerated cimetidine absorption.
January 1989, Therapeutic drug monitoring,
A Somogyi, and R Gugler
Cimetidine and ranitidine increase midazolam bioavailability.
January 1987, Clinical pharmacology and therapeutics,
A Somogyi, and R Gugler
Cimetidine bioavailability and variable renal clearance.
January 1984, European journal of clinical pharmacology,
Copied contents to your clipboard!